Skip to main content
Geratherm Medical AG logo

Geratherm Medical AG — Investor Relations & Filings

Ticker · GME ISIN · DE0005495626 LEI · 391200RRY20H0XD6QC53 F Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 483 across all filing types
Latest filing 2023-08-25 Interim / Quarterly Rep…
Country DE Germany
Listing F GME

About Geratherm Medical AG

https://geratherm.com/

Geratherm Medical AG is a medical technology company that develops and produces a range of medical devices and solutions for both professional and home use. For the professional market, the company provides systems for pulmonary function diagnostics, including spirometry, pulmonary function tests (PFT), and cardiopulmonary stress tests (CPET). It also offers specialized equipment such as the nomag®IC advanced, an MR diagnostics incubator system for newborns. For the consumer and home care market, Geratherm offers a portfolio of healthcare diagnostic products designed to monitor vital data. This includes clinical thermometers, blood pressure monitors, and products for women's health, such as pregnancy tests and tools for natural family planning.

Recent filings

Filing Released Lang Actions
Halbjahresabschluss 2023
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Zwischenbericht des Vorstands über das I. Halbjahr 2023' (Interim Report of the Management Board for the first half of 2023). It contains comprehensive financial data, including a consolidated balance sheet, income statement analysis, and management commentary on business performance for the six-month period ending June 30, 2023. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial statements and analysis for a period shorter than a full fiscal year. H2 2023
2023-08-25 German
Report Publication Announcement 2023
Report Publication Announcement Classification · 100% confidence The document is extremely short (1793 characters) and explicitly states that it is a 'Preliminary announcement of the publication of financial reports'. It specifies the report type as 'Financial report of the group (half-year/Q2)' and provides the future 'Date of disclosure: August 25, 2023'. According to Rule 2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report will be published or is attached classifies as a Report Publication Announcement (RPA), not the report itself (which would be an IR for a half-year report).
2023-08-23 English
Hinweis auf Halbjahresfinanzbericht vom 01.01.2023 bis zum 30.06.2023
Report Publication Announcement Classification · 98% confidence The document text is very short (811 characters) and explicitly functions as a notice. The key elements are 'Hinweis auf Halbjahresfinanzbericht' (Notice of Half-Year Financial Report) and it provides a link and date where the actual report can be found ('Der Finanzbericht steht zur Verfügung: Im Internet unter: ...'). According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report is available elsewhere should be classified as a Report Publication Announcement (RPA). The report itself is a half-year report, which would typically be an 'IR' (Interim Report), but this document is merely the announcement of its publication.
2023-08-23 German
Jahresabschluss 2022
Annual Report Classification · 100% confidence The document is titled 'Geschäftsbericht 2022' (Annual Report 2022) for Geratherm Medical AG. It contains comprehensive financial information, including the management report (Konzernlagebericht), consolidated financial statements (Konzernjahresabschluss), the auditor's report (Bestätigungsvermerk), and reports from the Supervisory Board and Management Board. It covers the full fiscal year 2022 and provides detailed financial data, meeting the criteria for an Annual Report (10-K). FY 2022
2023-08-22 German
Geratherm Medical AG: Veroffentlichung einer Kapitalmarktinformation
Transaction in Own Shares Classification · 100% confidence The document is titled 'Geratherm Medical AG: Veröffentlichung einer Kapitalmarktinformation' and explicitly mentions 'Aktienrückkauf: Bekanntmachung nach Artikel 5 Abs. 1 b) und Abs. 3 der Verordnung (EU) Nr.596/2014' and 'Erwerb eigener Aktien – 28. Zwischenmeldung'. This content details the company's ongoing share repurchase program, including daily transaction volumes and average prices for a specific period (August 7 to August 11, 2023). This directly relates to the company buying back or selling its own shares. Therefore, the most appropriate classification is Transaction in Own Shares (POS). Although it is a regulatory announcement, POS is more specific than the general RNS or RPA categories.
2023-08-14 German
Geratherm Medical AG: Veroffentlichung einer Kapitalmarktinformation
Transaction in Own Shares Classification · 100% confidence The document is titled "Geratherm Medical AG: Veröffentlichung einer Kapitalmarktinformation" and explicitly concerns the "Aktienrückkauf: Bekanntmachung nach Artikel 5 Abs. 1 b) und Abs. 3 der Verordnung (EU) Nr.596/2014" (Share Buyback: Announcement according to Article 5...). It details the number of shares repurchased over a specific period (July 24 to July 28, 2023). This is a report detailing the company's transaction in its own shares (share repurchase). The corresponding category is 'Transaction in Own Shares' (POS). Although it is an announcement, the content is the detailed transaction data itself, not just a notice that a report is available, making POS more specific than RPA or RNS.
2023-07-31 German

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.